Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines (Q39732359)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines (English)

1 reference

Europe PubMed Central

14 September 2017

1 reference

based on heuristic

inferred from title

author name string

Chien-Liang Chen

1

1 reference

Europe PubMed Central

14 September 2017

Kang-Ju Chou

2

1 reference

Europe PubMed Central

14 September 2017

Po-Tsang Lee

3

1 reference

Europe PubMed Central

14 September 2017

Ying-Shou Chen

4

1 reference

Europe PubMed Central

14 September 2017

Tsu-Yuan Chang

5

1 reference

Europe PubMed Central

14 September 2017

Chih-Yang Hsu

6

1 reference

Europe PubMed Central

14 September 2017

Wei-Chieh Huang

7

1 reference

Europe PubMed Central

14 September 2017

Hsiao-Min Chung

8

1 reference

Europe PubMed Central

14 September 2017

Hua-Chang Fang

9

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

2 March 2010

1 reference

Europe PubMed Central

14 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

14 September 2017

316

1 reference

Europe PubMed Central

14 September 2017

7

1 reference

Europe PubMed Central

14 September 2017

1109-1118

1 reference

Europe PubMed Central

14 September 2017

An overview of epithelio-mesenchymal transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial-mesenchymal transition and its implications for fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Evidence that fibroblasts derive from epithelium during tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

How cells read TGF-beta signals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Regulation of Smad activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.02.022

7 January 2021

Identifiers

10.1016/J.YEXCR.2010.02.022

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39732359&oldid=2089196449"